Marius Gensler

Papers

Total Citations

H-Index

About

Marius Gensler is a pioneering researcher at the intersection of robotics and tissue engineering, whose work is reshaping preclinical drug testing. His primary research areas include biological automation, 3D tissue production, and the development of animal-free testing platforms. Gensler’s major contribution is the ReBiA (Robotic Enabled Biological Automation) system, which automates the production of 3D epithelial tissues—a breakthrough that directly addresses the global shift away from animal testing. His most-cited paper, "ReBiA—Robotic Enabled Biological Automation: 3D Epithelial Tissue Production" (2024, 13 citations), aligns with the FDA’s recent decision to eliminate mandatory animal testing for drug approval and the European Parliament’s push for faster adoption of alternative methods. This work not only demonstrates technical innovation but also responds to public demand for ethical research practices. Gensler’s achievements position him as a key figure in the transition to human-relevant, automated tissue models, offering scalable solutions that could accelerate drug development while reducing reliance on animal models. His research holds promise for transforming regulatory toxicology and personalized medicine.